Sangamo BioSciences | Nettoeinkommen



Net Income Veränderung Datum
Alaunos Therapeutics USD -742000 385K 2024-12
Alnylam Pharmaceuticals USD -57479000 26.28M 2025-03
Amgen USD 1.73B 1.1B 2025-03
Bayer EUR 1.3B 1.63B 2025-03
Biogen USD 240.5M 26.2M 2025-03
BioMarin Pharmaceutical USD 185.69M 60.74M 2025-03
Cipla INR 12.22B 3.49B 2025-03
Clal Biotechnology ILS -6166000 15.56M 2022-12
Compugen USD -6117000 7.39M 2024-12
CSL USD 2.01B 1.27B 2024-12
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 1.62B 1.21B 2025-03
Grifols EUR 68.97M 17.28M 2024-12
Ionis Pharmaceuticals USD -146938000 42.59M 2025-03
J&J USD 11B 7.57B 2025-03
Merck USD 5.08B 1.34B 2025-03
Novartis USD 2.82B 371M 2024-12
Pfizer USD 2.97B 2.56B 2025-03
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 1.87B 1.37B 2025-03
Sarepta Therapeutics USD -447508000 606.56M 2025-03
Tectonic Therapeutic USD -12373000 5.34M 2024-12
Ultragenyx Pharmaceutical USD -151080000 17.7M 2025-03
Vertex Pharmaceuticals USD 913M 132.4M 2024-12



Sangamo BioSciences Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.